Alnylam Pharmaceuticals Inc (ALNY)
Alnylam Receives European Commission Approval forAMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Alnylam Receives European Commission Approval forAMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy
There are no comments here yet...